Intended for healthcare professionals
Search
Toggle navigation
Current issue
Archive
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
Editorial board
For authors
Advertising
Contact us
News
Web Exclusives
Register
FREE
Sign in
×
Remember me
Not registered?
Forgot your password?
Comment: Where are we going?
Neil Cox
Writing this editorial for the new millennium (mill = empty, ennium = supermarkets) I ask myself what the future holds for those of us who survived the New Year celebrations. I am exercising editorial privilege in narrowmindedly concentrating on matters which affect dermatology and dermatologists. My greatest concern is the 'Big Brother' culture which has taken over medicine.
Dermatology in practice
2000;
8
(1): 4–4
To continue reading this article, please
sign in
or
register
.
Follow us on
|
|
Latest News
J&J/Protagonist’s icotrokinra shows promise in phase 3 plaque psoriasis trial
UCB’s Bimzelx approved by FDA to treat hidradenitis suppurativa
LEO Pharma announces long-term results for Adbry in atopic dermatitis
FDA approves Journey Medical’s Emrosi for adults with rosacea
Dermavant’s Vtama cream shows promise in long-term atopic dermatitis study
This site uses cookies in order to function properly and to allow us to improve our service. By using this site you consent to the use of cookies as set out in our
privacy policy